Episurf Medical (Sweden) Performance
| EPIS-B Stock | SEK 0.13 0.01 8.33% |
On a scale of 0 to 100, Episurf Medical holds a performance score of 3. The firm shows a Beta (market volatility) of -0.74, which means possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Episurf Medical are expected to decrease at a much lower rate. During the bear market, Episurf Medical is likely to outperform the market. Please check Episurf Medical's downside deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to make a quick decision on whether Episurf Medical's price patterns will revert.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Episurf Medical AB are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain forward indicators, Episurf Medical sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 155 M | |
| Total Cashflows From Investing Activities | -6.5 M |
Episurf |
Episurf Medical Relative Risk vs. Return Landscape
If you would invest 12.00 in Episurf Medical AB on December 19, 2024 and sell it today you would earn a total of 1.00 from holding Episurf Medical AB or generate 8.33% return on investment over 90 days. Episurf Medical AB is generating 0.295% of daily returns and assumes 5.8259% volatility on return distribution over the 90 days horizon. Simply put, 51% of stocks are less volatile than Episurf, and 95% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Episurf Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Episurf Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Episurf Medical AB, and traders can use it to determine the average amount a Episurf Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0506
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | EPIS-B | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.83 actual daily | 52 52% of assets are less volatile |
Expected Return
| 0.3 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Episurf Medical is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Episurf Medical by adding it to a well-diversified portfolio.
Episurf Medical Fundamentals Growth
Episurf Stock prices reflect investors' perceptions of the future prospects and financial health of Episurf Medical, and Episurf Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Episurf Stock performance.
| Return On Equity | -0.45 | |||
| Return On Asset | -0.26 | |||
| Operating Margin | (11.71) % | |||
| Current Valuation | 291.48 M | |||
| Shares Outstanding | 266.43 M | |||
| Price To Earning | (2.21) X | |||
| Price To Book | 2.31 X | |||
| Price To Sales | 74.39 X | |||
| Revenue | 6.5 M | |||
| EBITDA | (61.7 M) | |||
| Cash And Equivalents | 59 M | |||
| Cash Per Share | 0.65 X | |||
| Total Debt | 800 K | |||
| Debt To Equity | 8.80 % | |||
| Book Value Per Share | 0.75 X | |||
| Cash Flow From Operations | (59.7 M) | |||
| Earnings Per Share | (0.29) X | |||
| Total Asset | 270.6 M | |||
| Retained Earnings | (175 M) | |||
| Current Asset | 61 M | |||
| Current Liabilities | 6 M | |||
About Episurf Medical Performance
By analyzing Episurf Medical's fundamental ratios, stakeholders can gain valuable insights into Episurf Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Episurf Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Episurf Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Episurf Medical AB , a medical device company, designs and manufactures implants and surgical instruments in the Nordic countries, Benelux, Germany, and the United Kingdom. Episurf Medical AB was founded in 2008 and is headquartered in Stockholm, Sweden. Episurf Medical is traded on Stockholm Stock Exchange in Sweden.Things to note about Episurf Medical AB performance evaluation
Checking the ongoing alerts about Episurf Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Episurf Medical AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Episurf Medical AB had very high historical volatility over the last 90 days | |
| Episurf Medical AB has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 6.5 M. Net Loss for the year was (69.3 M) with loss before overhead, payroll, taxes, and interest of (28.5 M). | |
| Episurf Medical AB has accumulated about 59 M in cash with (59.7 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.65, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 21.0% of the company shares are held by company insiders |
- Analyzing Episurf Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Episurf Medical's stock is overvalued or undervalued compared to its peers.
- Examining Episurf Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Episurf Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Episurf Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Episurf Medical's stock. These opinions can provide insight into Episurf Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Episurf Stock analysis
When running Episurf Medical's price analysis, check to measure Episurf Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Episurf Medical is operating at the current time. Most of Episurf Medical's value examination focuses on studying past and present price action to predict the probability of Episurf Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Episurf Medical's price. Additionally, you may evaluate how the addition of Episurf Medical to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |